Table 4.
Ingenuity Canonical Pathways* | P† | Ratio | Molecules |
Glycerophospholipid metabolism | .004 | 3.11E-02 | PPAP2B, PLA2R1, CHKA, AGPAT1, PGS1, PCYT1A |
N-glycan biosynthesis | .028 | 3.23E-02 | B4GALT4, ST6GAL1, MAN1C1 |
Riboflavin metabolism | .028 | 3.64E-02 | ACP5, ACP1 |
Arachidonic acid metabolism | .045 | 1.76E-02 | CYP2F1, CYP1A1, PLA2R1, PLOD1 |
Linoleic acid metabolism | .048 | 2.42E-02 | CYP2F1, CYP1A1, PLA2R1 |
Sphingolipid metabolism | .059 | 2.68E-02 | NAGA, PPAP2B, ASAH1 |
AMPK signaling | .100 | 2.41E-02 | MTOR, ACACB, STRADA, PPM1D |
Glycerolipid metabolism | .104 | 1.92E-02 | NAGA, PPAP2B, AGPAT1 |
EIF2 signaling | .107 | 3E-02 | EIF2C2, EIF2AK2, GSK3B |
Ingenuity Pathway Analysis (IPA), Version 8, www.ingenuity.com.
P values from IPA are Benjamini-Hochberg corrected.